The cap raise was to fund a combination trial that immutep will fund and control assisted by Merck providing keytruda
which otherwise would have needed to have been purchased by immutep for said trial…
Ann: Immutep completes institutional pro-rata offer & placement, page-27
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 41.0¢ | 39.5¢ | $1.157M | 2.892M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 210986 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 173168 | 16 |
View Market Depth
| Last trade - 15.36pm 11/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |